about
Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controlsThe kynurenic acid hypothesis of schizophreniaBehavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.CSF biomarkers in suicide attempters--a principal component analysis.Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.Connecting inflammation with glutamate agonism in suicidality.The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.The kynurenine pathway in schizophrenia and bipolar disorder.Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression.Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters.Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct.Activation of brain interleukin-1beta in schizophrenia.Imbalanced kynurenine pathway in schizophrenia.Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons.Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo.Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.The anaesthetic agent propofol interacts with GABA(B)-receptors: an electrophysiological study in rat.Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.Endogenous kynurenic acid disrupts prepulse inhibition.Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis.Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons.Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia.Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors.Activation of nigral dopamine neurons by the selective GABA(B)-receptor antagonist SCH 50911.
P50
Q24623659-C64B0630-A5F9-4325-8A45-76E4D507F71BQ28306552-F10ADA76-CD43-417A-91B7-523609968514Q30419650-C2D02F5B-CA10-446E-BE0A-B2B9706EC6C3Q30475641-019757D9-9C45-4B69-ABC1-85E0629ECA13Q33572850-D5FE2556-731F-408F-A229-5329903D7BDAQ33783832-FD15D383-DF8F-4D58-91DC-8C577CD89BF0Q33816563-17897C70-285A-48F8-995E-ADAC4EED2885Q35162796-AED08EAC-0661-40B1-8BA8-4B0795601C47Q36901111-A32BBE87-8D68-46F8-9659-4F415654BEA7Q37186953-3BE3F106-4046-4A8A-8B43-85E59992B934Q37378691-402A7877-95AD-4DC6-A2F3-8DE32989200DQ38849243-115DA240-CE3D-45FB-B96A-43FDC9E17AF8Q39269171-5DDE1937-695E-481B-A6C6-9856F248589CQ39537190-6E79C448-0A70-4848-BC89-5125EB7CF63CQ39777451-3ADF1E57-8DA2-4110-8711-5104BF97309CQ41771344-8633CD07-7A52-43EF-9BD6-7A8D1B753BAFQ42164271-FA513177-79EA-4D4A-B484-EE1E96AAD9F9Q42528519-AEE2010D-E781-42F8-BA2D-C2350E0DBA16Q42852301-CEED979A-D4AC-4D50-A331-BBA9F2CC3AA1Q42921229-C515D1C1-63E4-4EE8-B91E-A5116E6FCE5DQ43673567-40D4C3F1-C590-4978-B7AF-C3840677E7E9Q43783037-151E2EF0-FD6D-44C4-BC7C-1F104C17E88FQ43908487-BF3D3A2B-47B9-4633-8CB0-27A1E232B384Q43975284-D687158C-5037-4250-BAE3-AA8A75780FF3Q44392634-12644F8D-9F58-4895-A665-4777C04D2A69Q44515021-E075D6AC-F782-4600-BA24-52D2D9F46346Q44808036-F62A874C-2256-4DCE-A367-5703711DE3C3Q45019400-92EF0F74-BE4F-4F4E-A0BF-862BA4D25217Q45287107-C31C9D49-749F-4027-BD0E-56A69F08DD32Q45507327-1B327A25-054F-4B9C-99CD-8AA865DB8B26Q46096621-5BF80D2A-274C-47D8-9420-CB3991369FD7Q46364104-1FE7E56D-D8A8-485B-A8E9-BCC3EB268B45Q46509954-CE3791F6-C134-443E-8F77-3444D2958EC9Q46636521-89BB8C69-3485-4007-94E8-8977D9710B41Q46672881-1E4A1F65-8827-49DA-A6F2-FC2D97F26650Q46896546-25D4AE50-4295-4139-A4CC-D356A00901E0Q46909575-8AB1EDE2-573F-423F-963D-AFD64D19E5E9Q46933332-922903EE-7DA5-4E8D-878B-FBA246A03450Q47755623-7D169B7F-2B55-41C5-AAD3-A3965021DB66Q48139396-42DC5563-7A38-4A41-91D1-8ACA0397AB71
P50
description
hulumtuese
@sq
professor vid Karolinska Institutet
@sv
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Sophie Erhardt
@ast
Sophie Erhardt
@en
Sophie Erhardt
@es
Sophie Erhardt
@nl
Sophie Erhardt
@sl
Sophie Erhardt
@sv
type
label
Sophie Erhardt
@ast
Sophie Erhardt
@en
Sophie Erhardt
@es
Sophie Erhardt
@nl
Sophie Erhardt
@sl
Sophie Erhardt
@sv
altLabel
Karin Sophie Margareta Erhardt
@sv
prefLabel
Sophie Erhardt
@ast
Sophie Erhardt
@en
Sophie Erhardt
@es
Sophie Erhardt
@nl
Sophie Erhardt
@sl
Sophie Erhardt
@sv
P214
P227
P106
P2038
Sophie_Erhardt
P21
P214
P227
1025667980
P31
P496
0000-0001-7359-5250
P569
1972-03-28T00:00:00Z
P735
P7859
viaf-262617484